Scarica l'app Stockscreener
186.43
0.44%
0.81
Pre-mercato:
187.07
0.64
+0.34%
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
QTS Forecast — Price Target — Prediction for 2027 - TradingView
IQVIA Holdings chart picture stays robust, shares above key 200-day mark - Ad-hoc-news.de
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
IQVIA Holdings Inc (IQV) Shares Surge 8.4% -- What GF Score of 8 - GuruFocus
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage - MSN
Pharmacovigilance Automation Market Size to Reach USD 5.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
OCE from IQVIA Holdings Inc.cloud CRM that speaks pharma’s language - Ad-hoc-news.de
Does Slower Growth at IQVIA Holdings (IQV) Challenge Its Core Data‑Driven Pharma Enablement Story? - Yahoo Finance
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IQVIA Holdings trades in a tight range, technicals flag cautious signal for the shares - AD HOC NEWS
IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IQVIA Holdings analyst views shift, shares trade below recent targets - Ad-hoc-news.de
IQVIA Holdings, Inc. (IQV): Investor Outlook On A 34% Potential Upside - DirectorsTalk Interviews
IQVIA HoldingsAnalyst consensus and long-term drivers - AD HOC NEWS
Why IQVIA’s Orchestrated Customer Engagement quietly shapes pharma sales - AD HOC NEWS
IQVIA Holdings StockMorgan Stanley cuts rating and trims target - Ad-hoc-news.de
Morgan Stanley Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $225 - Moomoo
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
IQVIA Holdings Inc (IQV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IQVIA Holdings Inc (IQV) Valuation: PE, PB & Fair Value Analysis - TradingKey
IQVIA Holdings Inc (IQV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IQVIA Holdings Inc (IQV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IQVIA Holdings Inc (IQV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IQVIA Holdings Inc (IQV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Saratoga Health & Biotechnology Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc (IQV) Institutional Confidence - TradingKey
IQVIA Holdings Inc (IQV) Stock Price, Trades & News - GuruFocus
Is IQVIA Holdings Inc (IQV) a Bargain After 4.7% Drop? GF Value Says Undervalued - GuruFocus
IQVIA Holdings Inc (IQV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA Holdings, Inc. Stock 12‑Month Price Target Cut to $223.28, Implies 25% Upside - TradingView
IQV Downgraded by Morgan Stanley -- Price Target Lowered to $200 - GuruFocus
Why is IQVIA Holdings stock sliding today? By Investing.com - Investing.com Nigeria
Morgan Stanley Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts Price Target to $200 From $225 - marketscreener.com
Morgan Stanley downgrades IQVIA stock rating on margin concerns - Investing.com UK
Morgan Stanley Downgrades IQVIA Holdings(IQV.US) to Hold Rating, Cuts Target Price to $200 - Moomoo
(IQV) Risk Channels and Responsive Allocation - Stock Traders Daily
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity - The Globe and Mail
IQVIA Holdings Stock (US46266C1053): Analyst Views and Valuation Under the Microscope - AD HOC NEWS
Here's why IQVIA Holdings (IQV) is a strong momentum stock - MSN
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain - Financial Times
IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Innovation - DirectorsTalk Interviews
More than 25 health leaders flag AI choke points from lab to patient - Stock Titan
IQV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is IQVIA Holdings stock outperforming the Dow? - MSN
IQVIA Is More Than a Contract Research Outsourcing Trade - AlphaStreet
IQVIA HOLDINGS INC CMNRo Khanna Congressional Trade on May. 27, 2026 - Quiver Quantitative
IQVIA Holdings Inc. Indenture and 8-K Filing Details for Notes Issuance (June 11, 2026) - Minichart
IQVIA Holdings Stock (US46266C1053): sector peers frame the valuation debate - AD HOC NEWS
IQVIA Holdings Inc. (IQV) Announces €950 Million Notes Offering - GuruFocus
IQVIA Raises €950 Million Via 4.625% Senior Notes Due 2033 to Refinance Debt - TradingView
€950M 4.625% 2033 notes support IQVIA (NYSE: IQV) debt refinancing - Stock Titan
IQVIA (IQV) Q1 2026 Earnings Call Transcript - AOL.com
IQVIA Holdings earnings preview: What to expect - MSN
1.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):